Latest news for Playgon Games (OTC:PLGNF) Stock

Playgon Games Inc is a technology company. It focuses on developing and licensing digital content for the growing iGaming market. The company provides a multi-tenant gateway that allows online operators the ability to offer customers iGaming software solutions. Its current software platform includes Live Dealer Casino, E-Table games, and Daily Fantasy Sports. The firm's products are turn-key solutions for online casinos, sportsbook operators, land-based operators, media groups, and database companies. The Company generates Software as a service (SAAS) revenue from contracts with customers by providing them access to the Company's Live Dealer Product.

News

Previews

Sports

Events

Markets

Trading Ideas

ETFs

General

ATVI

PLGNF

TSXV:DEAL

POPRF

TSXV:POPR

GENTF

ASGRF

PSDMF

GMSQF

CSE:GSQ

LEOVF

FUNFF

CSE:FANS

TGSEF

TSXV:TGS

LUKEF

TSXV:LUCK

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.

As 2021 continues, some of the biggest trends of last year are also continuing, including the huge growth of esports and video games. 

11 Emerging Companies that Could Benefit from the Growth of Esports and Gaming

Playgon Games Inc

<a href="https://ipsearch.ipaustralia.gov.au/patents/2018237549" title="https://ipsearch.ipaustralia.gov.au/patents/2018237549">https://ipsearch.ipaustralia.gov.au/patents/2018237549</a>

Biotech

VCNX

Vaccinex Has Been Granted Australian Patent Number 2018237549 Titled "Treatment Of Cancer With A Semaphorin-4d Antibody In Combination With An Epigenetic Modulating Agent"

Kelly Slater, the 11-time World Surf League champion, recently joined the growing conversation around psychedelics. In an <a href="https://www.si.com/onsi/everyday-warrior-nation/everyday-warrior-podcast/kelly-slater-on-psychedelics-the-emerging-frontier-for-mental-health-and-human-performance">appearance</a> on the Everyday Warrior podcast, Slater discussed their transformative <a href="https://www.benzinga.com/topic/psychedelic-assisted-therapies">potential for mental health</a> and human performance. 
Widely considered the greatest surfer of all time, Slater's endorsement of psychedelics, when used responsibly, marks a significant shift in how these substances are perceived, moving from counterculture to a legitimate tool for healing and personal growth.
<h3 class="wp-block-heading">Science Behind Psychedelic Therapy</h3>
Research into psychedelics, particularly <a href="https://www.benzinga.com/topic/psilocybin">psilocybin</a> and <a href="https://www.benzinga.com/topic/mdma">MDMA</a>, has gained momentum in recent years. Clinical studies from prestigious institutions like Johns Hopkins University show that psilocybin can effectively reduce symptoms of depression and anxiety, especially in treatment-resistant cases. Similarly, MDMA-assisted therapy has received FDA "breakthrough therapy" status for its success in treating PTSD.
Slater, a vocal advocate for wellness, agrees with the growing evidence. "Like a medicine of all types, used properly with the right approach is beneficial." He highlights the importance of a structured, medically supervised environment to ensure that psychedelics can be used safely and effectively.
<h3 class="wp-block-heading">Psychedelics And Peak Performance</h3>
While Slater has historically been cautious about drugs, he acknowledges that psychedelics can be a powerful tool for self-discovery and peak performance when used responsibly. "It's about opening up your mind in a safe and controlled way to improve your mental state and performance," he said.
Beyond healing trauma, psychedelics are increasingly used to enhance human performance. <a href="https://www.benzinga.com/markets/cannabis/24/11/41814007/pro-golfers-turn-to-psychedelics-for-focus-boost-and-anxiety-relief">Athletes</a> and entrepreneurs alike are experimenting with psychedelics for creativity, focus, and flow. NFL quarterback Aaron Rodgers, for instance, has<a href="https://www.benzinga.com/markets/cannabis/22/08/28358173/aaron-rodgers-says-ayahuasca-helped-him-achieve-best-season-of-his-career-love-himself"> credited his experience with ayahuasca</a> for improving his mental clarity and resilience.
<h3 class="wp-block-heading">A Call for Responsible Use</h3>
Despite the growing interest in psychedelics, Slater remains cautious about their misuse. "Most people figure out some way to abuse anything in life," he cautioned, stressing the importance of responsible, medically supervised use. As cities like Denver, Oakland, and Portland <a href="https://www.benzinga.com/topic/psychedelics-decriminalization">decriminalize psychedelics</a>, and Oregon <a href="https://www.benzinga.com/markets/cannabis/20/11/18204455/oregon-becomes-first-us-state-to-decriminalize-drug-possession-begins-psilocybin-program">becomes the first state to legalize their therapeutic use</a>, there is increasing momentum for regulated access. However, federal legalization remains a contentious issue.
<h3 class="wp-block-heading">Looking Ahead</h3>
Psychedelics are on the cusp of mainstream acceptance, thanks in part to advocates like Kelly Slater. Whether for healing trauma, improving mental health, or unlocking peak performance, these substances hold significant promise. The key will be ensuring their safe, responsible integration into society's wellness toolkit.
Photo: MediaPunch/REX/Shutterstock

Cannabis

Psychedelics

Kelly Slater Talks Psychedelics: Healing Trauma And Unlocking Potential

Investors with a lot of money to spend have taken a bearish stance on TG Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGTX#NASDAQ">TGTX</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with TGTX, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 8 uncommon options trades for TG Therapeutics.
This isn't normal.
The overall sentiment of these big-money traders is split between 37% bullish and 50%, bearish.
Out of all of the special options we uncovered, 2 are puts, for a total amount of $335,818, and 6 are calls, for a total amount of $347,076.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $28.0 to $50.0 for TG Therapeutics over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for TG Therapeutics's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of TG Therapeutics's whale activity within a strike price range from $28.0 to $50.0 in the last 30 days. 
<h3>TG Therapeutics Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733172332_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TGTX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$23.5</td>
<td>$19.2</td>
<td>$20.33</td>
<td>$50.00</td>
<td>$195.1K</td>
<td>1</td>
<td align="right">96</td>
</tr>
<tr>
<td>TGTX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$17.0</td>
<td>$14.3</td>
<td>$14.5</td>
<td>$40.00</td>
<td>$140.6K</td>
<td>127</td>
<td align="right">97</td>
</tr>
<tr>
<td>TGTX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$7.6</td>
<td>$7.3</td>
<td>$7.3</td>
<td>$29.00</td>
<td>$72.2K</td>
<td>2</td>
<td align="right">170</td>
</tr>
<tr>
<td>TGTX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$7.2</td>
<td>$6.9</td>
<td>$7.2</td>
<td>$28.00</td>
<td>$71.9K</td>
<td>769</td>
<td align="right">170</td>
</tr>
<tr>
<td>TGTX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$0.95</td>
<td>$0.8</td>
<td>$0.9</td>
<td>$40.00</td>
<td>$57.9K</td>
<td>1.0K</td>
<td align="right">16</td>
</tr>
</tbody>
</table>

<h3>About TG Therapeutics</h3>
TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). and the company is developing TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb) for B-cell disorders which are under Phase 1 trial.
In light of the recent options history for TG Therapeutics, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of TG Therapeutics</h3>
<ul>
<li>Trading volume stands at 1,278,914, with TGTX's price up by 0.07%, positioned at $34.83.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 86 days.</li>
</ul>
<h3>What The Experts Say On TG Therapeutics</h3>
In the last month, 3 experts released ratings on this stock with an average target price of $40.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Goldman Sachs continues to hold a Neutral rating for TG Therapeutics, targeting a price of $22. 
&#x2A; An analyst from JP Morgan has decided to maintain their Overweight rating on TG Therapeutics, which currently sits at a price target of $43. 
&#x2A; Consistent in their evaluation, an analyst from HC Wainwright &amp; Co. keeps a Buy rating on TG Therapeutics with a target price of $55. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest TG Therapeutics options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

TGTX

This Is What Whales Are Betting On TG Therapeutics

Deep-pocketed investors have adopted a bearish approach towards Qualcomm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in QCOM usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 37 extraordinary options activities for Qualcomm. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 32% leaning bullish and 48% bearish. Among these notable options, 9 are puts, totaling $427,522, and 28 are calls, amounting to $1,701,088.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $75.0 to $310.0 for Qualcomm over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for Qualcomm options trades today is 1470.91 with a total volume of 26,859.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Qualcomm's big money trades within a strike price range of $75.0 to $310.0 over the last 30 days.
<h3>Qualcomm Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733172327_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>QCOM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$34.95</td>
<td>$32.35</td>
<td>$33.02</td>
<td>$170.00</td>
<td>$168.5K</td>
<td>163</td>
<td align="right">61</td>
</tr>
<tr>
<td>QCOM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$24.4</td>
<td>$22.55</td>
<td>$23.59</td>
<td>$200.00</td>
<td>$141.5K</td>
<td>450</td>
<td align="right">61</td>
</tr>
<tr>
<td>QCOM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$11.4</td>
<td>$11.2</td>
<td>$11.2</td>
<td>$190.00</td>
<td>$110.8K</td>
<td>1.0K</td>
<td align="right">108</td>
</tr>
<tr>
<td>QCOM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$18.2</td>
<td>$17.95</td>
<td>$18.01</td>
<td>$150.00</td>
<td>$107.8K</td>
<td>205</td>
<td align="right">60</td>
</tr>
<tr>
<td>QCOM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$35.75</td>
<td>$34.8</td>
<td>$35.22</td>
<td>$175.00</td>
<td>$105.6K</td>
<td>33</td>
<td align="right">30</td>
</tr>
</tbody>
</table>

<h3>About Qualcomm</h3>
Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G, 4G, and 5G networks. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones, as well as chips into automotive and Internet of Things markets.
<h3>Present Market Standing of Qualcomm</h3>
<ul>
<li>Currently trading with a volume of 5,940,666, the QCOM's price is up by 2.79%, now at $162.96. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 58 days.</li>
</ul>
<h3>Expert Opinions on Qualcomm</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $196.8.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Evercore ISI Group keeps a In-Line rating on Qualcomm with a target price of $199. 
&#x2A; Reflecting concerns, an analyst from Benchmark lowers its rating to Buy with a new price target of $240. 
&#x2A; An analyst from JP Morgan has decided to maintain their Overweight rating on Qualcomm, which currently sits at a price target of $195. 
&#x2A; An analyst from UBS persists with their Neutral rating on Qualcomm, maintaining a target price of $190. 
&#x2A; In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Neutral, setting a price target of $160. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Qualcomm with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

QCOM

Smart Money Is Betting Big In QCOM Options

Deep-pocketed investors have adopted a bearish approach towards Merck &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MRK usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 12 extraordinary options activities for Merck &amp; Co. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 41% leaning bullish and 58% bearish. Among these notable options, 4 are puts, totaling $162,182, and 8 are calls, amounting to $427,918.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $90.0 to $105.0 for Merck &amp; Co over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Merck &amp; Co's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Merck &amp; Co's substantial trades, within a strike price spectrum from $90.0 to $105.0 over the preceding 30 days.
<h3>Merck &amp; Co Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733172322_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MRK</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$21.1</td>
<td>$20.4</td>
<td>$20.4</td>
<td>$90.00</td>
<td>$81.6K</td>
<td>62</td>
<td align="right">22</td>
</tr>
<tr>
<td>MRK</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/06/24</td>
<td>$7.85</td>
<td>$7.7</td>
<td>$7.75</td>
<td>$93.00</td>
<td>$67.4K</td>
<td>4</td>
<td align="right">270</td>
</tr>
<tr>
<td>MRK</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.9</td>
<td>$2.89</td>
<td>$2.89</td>
<td>$100.00</td>
<td>$60.1K</td>
<td>5.4K</td>
<td align="right">647</td>
</tr>
<tr>
<td>MRK</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/06/24</td>
<td>$7.8</td>
<td>$7.45</td>
<td>$7.79</td>
<td>$93.00</td>
<td>$59.9K</td>
<td>4</td>
<td align="right">183</td>
</tr>
<tr>
<td>MRK</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/18/26</td>
<td>$15.05</td>
<td>$14.35</td>
<td>$15.1</td>
<td>$100.00</td>
<td>$52.8K</td>
<td>502</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

<h3>About Merck &amp; Co</h3>
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Having examined the options trading patterns of Merck &amp; Co, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Merck &amp; Co</h3>
<ul>
<li>Currently trading with a volume of 5,098,978, the MRK's price is down by -1.06%, now at $100.56. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 64 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Merck &amp; Co options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Merck & Co Unusual Options Activity For December 02

Logistic Properties of the Americas Shares Halted On Circuit Breaker To The Upside, Stock Now Up 88.8%

WIIM

LSPD

Lightspeed Commerce shares are trading lower after the company announced a strategic reorganization that will impact approximately 200 employees.

<a href="https://www.federalreserve.gov/newsevents/speech/waller20241202a.htm" title="https://www.federalreserve.gov/newsevents/speech/waller20241202a.htm">https://www.federalreserve.gov/newsevents/speech/waller20241202a.htm</a>

Macro Economic Events

Economics

Federal Reserve

Fed's Waller Says Average Inflation Targeting Framework Was Very Backward Looking And "Blew Up" Very Quickly; People Are Still Trying To Figure Out What The Current Framework Actually Means; Simpler May Be Better

<h2><a href="https://www.androidcentral.com/phones/qualcomm-snapdragon-8-elite-successor-price-rumors">https://www.androidcentral.com/phones/qualcomm-snapdragon-8-elite-successor-price-rumors</a></h2>
&nbsp;
<ul>
<li>Rumors state Qualcomm's Snapdragon 8 Elite "Gen 2" could see a "significant" price hike in 2025.</li>
<li>A report claims this is due to several "internal and external" factors that are a major catalyst behind this supposed price increase for OEMs and suppliers.</li>
<li>Samsung's Galaxy S25 series was previously rumored to be in line for a price increase due to Qualcomm's beefed-up Oryon core 8 Elite.</li>
</ul>

"Qualcomm's Next Flagship SoC Could See A 'Significant' Price Hike" - Android Central

ACHR

EVTL

LUNR

RKLB

Shares of aerospace companies are trading lower amid possible profit-taking. A recent media report also highlighted the potential impact of space junk on satellite traffic.

New set of flexible data center components will support the next generation of generative AI innovation and provide 12% more compute power, while improving availability and efficiency
At AWS re:Invent, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), today announced new data center components designed to support the next generation of artificial intelligence (AI) innovation and customers' evolving needs. These capabilities combine innovations in power, cooling, and hardware design to create a more energy efficient data center that will underpin further customer innovation. These new capabilities will be implemented globally in AWS's new data centers, and many components are already deployed in its existing data centers. To learn more, visit: <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DNUIrNGwUu14&amp;esheet=54159717&amp;newsitemid=20241201928268&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DNUIrNGwUu14&amp;index=1&amp;md5=83fc8f7b24d3e4901eaa6f23e6ed13e4">https://www.youtube.com/watch?v=NUIrNGwUu14</a>.

AMZN

AWS Announces New Data Center Components Designed To Support The Next Generation Of Artificial Intelligence Innovation And Customers' Evolving Needs

Global

ASML

Dutch Government Foreign Ministry Says Will Study New U.S. Restrictions On Export Of Chips Equipment To China; The Netherlands Shares U.S. Concerns Over 'Uncontrolled' Export Of Advanced Semiconductor Equipment; "Every Country Has Its Own Considerations" On National Security And Export Controls

According to Federal Reserve data, the <a href="https://www.benzinga.com/personal-finance/24/10/41193824/are-you-rich-enough-to-be-in-the-top-1-heres-both-the-income-and-net-worth-you-need-to-rank-amon">average retiree's net worth</a> is $1.79 million. Sounds impressive, right? But here's the catch: that number doesn't tell the whole story. A small group of ultra-wealthy individuals significantly skews the average, making it more of an illusion than a reality for most.
Don't Miss:
<ul>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
<li>The number of ‘401(k)' Millionaires is up 43% from last year —<a href="https://www.benzinga.com/money/401k-millionaires"> Here are three ways to join the club.</a></li>
</ul>
The median net worth for retirees aged 65 to 74 is just $409,900 – less than a quarter of that lofty $1.79 million. And it gets worse for those 75 and older, whose median net worth drops to $335,600. These figures paint a much more realistic picture of what the average retiree is working with.
Why does this matter? While $1.79 million sounds like a comfortable retirement, $409,900 is far less than most experts recommend saving for retirement. In reality, not everyone has a million stashed away; <a href="https://www.benzinga.com/personal-finance/24/08/40234360/can-you-guess-what-percent-of-retirees-have-1-million-saved-heres-a-look-at-the-net-worth-of-peo">only about 10% of retirees</a> reach this milestone.
See Also: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $100.</a>
Financial advisors often recommend saving at least 10 times your annual salary by age 67 to maintain your lifestyle in retirement. They suggest benchmarks to get there: save 1x your salary by 30, 3x by 40, 6x by 50 and 8x by 60. For example, if you earn $100,000 a year, you should ideally have $300,000 saved by 40 and $1 million by 60. Compare this to the median net worth of retirees and most Americans are falling behind.
The reality is even starker when you look at the broader population. Nearly half American households have no retirement savings at all. For those who do, the average 401(k) balance for people nearing retirement (ages 60–69) is just $182,100, according to Vanguard data. Even among diligent savers, these numbers fall well short of the 6x or 8x benchmarks recommended by experts.
A median net worth of $409,900 might seem like a solid foundation, but it doesn't stretch as far as you hope. For instance, if you invest it and generate a 5% return, that's about $20,500 annually. Add in Social Security, which averages around $20,000 annually and your total is roughly $40,500 annually.
Trending: ‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest TODAY for just $0.26/share with a $1000 minimum.</a>
In a low-cost area, this might be manageable – but it's far from luxurious. Add in inflation, rising health care costs and the unexpected, like needing long-term care and it quickly becomes clear that $409,900 is not enough.
A lack of savings can lead to financial strain in retirement, especially as credit-card debt among retirees is on the rise. EBRI.org reports that over the past 20 years, both the percentage of older people carrying debt and the amount of debt they carry has increased by 50%.
So, where does your net worth fall on the spectrum? Are you ahead of the curve or is there work to do?
If you're not where you want to be, now is the time to take action. Consider increasing your savings rate, exploring additional income streams or consulting a financial advisor to develop a plan tailored to your needs. Remember, it's never too late to improve your financial future.
Read Next:
<ul>
<li>Studies show 50% of consumers think Financial Advisors cost much more than they do —<a href="https://www.benzinga.com/money/money-pickle"> to debunk this, this company provides matching for free and a complimentary first call with the matched advisor.</a></li>
<li>Many are using this retirement income calculator to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a></li>
</ul>

Personal Finance

The Average Retiree Has A Net Worth Of $1.79 Million – Are You Ahead Of The Curve?

In the current market session, IBM Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) stock price is at $227.20, after a 0.09% decrease. However, over the past month, the company's stock spiked by 9.64%, and in the past year, by 41.01%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2024/1733171416_0.png" alt="Past Year Chart" />

<h3>Evaluating IBM P/E in Comparison to Its Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
IBM has a lower P/E than the aggregate P/E of 96.16 of the IT Services industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1733171416_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

P/E Ratio Insights for IBM

<a href="https://www.bloomberg.com/news/articles/2024-12-02/grifols-shareholder-mason-capital-calls-for-board-to-be-replaced?sref=y3YMCJ4e">https://www.bloomberg.com/news/articles/2024-12-02/grifols-shareholder-mason-capital-calls-for-board-to-be-replaced?sref=y3YMCJ4e</a>
<a href="https://www.bloomberg.com/quote/0217620D:US">Mason Capital Management LLC</a>'s Kenneth M Garschina said he wants <a href="https://www.bloomberg.com/quote/GRF:SM">Grifols SA</a>'s board replaced.
The co-founder of the New York-based hedge fund demanded a seat on the Grifols board during <a href="https://www.bloomberg.com/quote/BAM:US">Brookfield Asset Management</a>'s failed attempt to win control of the company. Now he's orchestrating a campaign to revamp the drug maker's board, namely by ousting Tomas Daga, a veteran director and long-time friend of the founding family.

Management

GRFS

'Grifols Shareholder Mason Capital Calls For Board Overhaul' - Bloomberg News

Core Scientific, Inc. - Class A Common Stock

CORZ

Core Scientific shares are trading lower after the company announced its intention to offer $500 million in convertible senior notes due 2031 in a private offering.

<a href="https://www.travelandtourworld.com/news/article/marriott-brings-the-ritz-carlton-to-serbia-in-landmark-collaboration/#:~:text=Marriott%20International%2C%20Inc.%20has%20entered,design%20to%20the%20capital%20city.">https://www.travelandtourworld.com/news/article/marriott-brings-the-ritz-carlton-to-serbia-in-landmark-collaboration/#:~:text=Marriott%20International%2C%20Inc.%20has%20entered,design%20to%20the%20capital%20city.</a>
Marriott International, Inc. has entered into a partnership with Danube Riverside d.o.o. Beograd to debut The Ritz-Carlton brand in Serbia. Set to open in 2027, The Ritz-Carlton, Belgrade will bring the brand's renowned luxury service and sophisticated design to the capital city.

'Marriott Brings The Ritz-Carlton To Serbia In Landmark Collaboration' - Travel And Tour World

<a href="https://status.coinbase.com/">https://status.coinbase.com/</a>
Investigating - Due to an Interac outage, withdrawals via Interac for Canadian customers will be delayed. We are investigating this issue and will provide an update shortly. Dec 02, 2024 - 10:47 PST

COIN

Coinbase Says Due To An Interac Outage, Withdrawals Via Interac For Canadian Customers Will Be Delayed; Investigating Issue

Comdata retains fuel card and payment acceptance business serving commercial fleets
ATLANTA, Dec. 2, 2024 /PRNewswire/ --&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4315311-1&amp;h=3408367530&amp;u=https%3A%2F%2Fpditechnologies.com%2F%3Futm_source%3Dprnewswire%26utm_medium%3Dpress-release%26utm_campaign%3Dcomdata-2024&amp;a=PDI+Technologies">PDI Technologies</a>, a global leader delivering powerful solutions and insights that serve as the backbone of the convenience retail and petroleum wholesale ecosystem, today announced its acquisition of the Comdata Merchant Solutions business from Comdata's parent company, <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4315311-1&amp;h=201151909&amp;u=https%3A%2F%2Fwww.corpay.com%2F&amp;a=Corpay+Inc.">Corpay Inc.</a>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPAY#NYSE">CPAY</a>). This includes the <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4315311-1&amp;h=2454231519&amp;u=https%3A%2F%2Fcomdatafuelsolutions.com%2F&amp;a=Point+of+Sale+(POS)+hardware%2C+software%2C+and+systems">Point of Sale (POS) hardware, software, and systems</a>&nbsp;that enable transactions at the site level for truck stops and unattended commercial fueling locations.&nbsp;
PDI currently offers a market-tested <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4315311-1&amp;h=3210960620&amp;u=https%3A%2F%2Fpditechnologies.com%2Fincrease-productivity%2Fstore-systems%2Fpoint-of-sale%2F%3Futm_source%3Dprnewswire%26utm_medium%3Dpress-release%26utm_campaign%3Dcomdata-2024&amp;a=POS+retail+solution">POS retail solution</a>&nbsp;internationally, including convenience customer sites in North America as of Q4 2024. Designed for its versatility in both retail fuel and convenience, the all-in-one software platform provides cloud-centric POS, self-checkout, and foodservice capabilities. The addition of the Comdata Merchant Solutions assets and technologies to the existing PDI retail offering expands and strengthens the PDI POS portfolio.

CPAY

PDI Technologies Announced Its Acquisition Of The Comdata Merchant Solutions Business From Comdata's Parent Company, Corpay Inc., Including The Point Of Sale Hardware, Software, And Systems That Enable Transactions At The Site Level For Truck Stops And Unattended Commercial Fueling Locations; No Financial Terms Disclosed

Core Scientific, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>) shares are trading lower Monday potentially following the company's announcement of a proposed offering of $500 million in convertible senior notes due 2031. Here&#8217;s <a href="https://www.benzinga.com/quote/CORZ/news">what you need to know.</a>
What To Know: The notes are being offered in a private placement to institutional buyers under Rule 144A of the Securities Act of 1933. These senior notes will be unsecured obligations. They will accrue interest payable semi-annually and mature on June 15 2031, unless converted, redeemed, or repurchased earlier.
Core Scientific has provided conditions under which the notes can be converted to cash, shares or a combination of both. The company also outlined specific scenarios for redemption and repurchase, including an option for noteholders to require repurchase if certain fundamental changes occur.
The proceeds from this offering are earmarked for general corporate purposes, including working capital, operating expenses and potential acquisitions. The terms of the notes, including the interest rate and conversion rate, will be finalized upon pricing the offering. However, concerns surrounding increased debt and the potential impact on shareholder equity appear to be weighing on the stock.
CORZ Price Action: Core Scientific shares were down 10.7% at $15.92 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://benzinga.slack.com/archives/D072651PB4K/p1733167806337199"><img loading="lazy" decoding="async" width="1024" height="550" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/02150901/CORZ-1024x550.png" alt="" class="wp-image-673151" style="width:439px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/02150901/CORZ-1024x550.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/02150901/CORZ-300x161.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/02150901/CORZ-768x412.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/02150901/CORZ.png 1164w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42274747/consumers-discretionary-outshines-sp-500-ahead-of-the-holidays-tesla-garmin-tapestry-lead-the-charge">Holiday Momentum Pushes Retail, Leisure Stocks Past S&amp;P 500 – Tesla, Garmin, Tapestry Stand Out</a></li>
</ul>
Photo Courtesy: Robert Way On Shutterstock.com.

Movers

Core Scientific Shares Are Falling Today: What's Going On?

Playgon Games suspends operations at Las Vegas studio

Press Releases

Playgon Reports Q1 2024 Financial and Operational Highlights and Provides Further Business Update

Playgon Games

Vancouver, British Columbia--(Newsfile Corp. - September 7, 2022) -&nbsp;Playgon Games Inc. (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/DEAL#TSXV">DEAL</a>) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/PLGNF#OTCQB">PLGNF</a>) (FSE: 7CR)&nbsp;and/or its subsidiaries (&quot;Playgon&quot; or the &quot;Company&quot;), a SaaS technology company focused on delivering mobile live dealer technology to online gaming operators worldwide, has signed a multi-jurisdictional software license and distribution agreement with global iGaming aggregator Pariplay Limited.

Pariplay&reg; is a tier one aggregator and content provider that service over 150+ operator accounts with innovative products including the Fusion&reg; aggregation platform. Founded in 2010, and now part of NeoGames S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NGMS#NASDAQ">NGMS</a>) Pariplay has offices in Malta, Israel, Bulgaria, Gibraltar, USA and India and is licensed and regulated by the Gibraltar Gambling Commission, the MGA, the UKGC, the Romanian National Gambling Office, the New Jersey DGE, the West Virginia Lottery, Michigan&#39;s MGBC, Ontario&#39;s AGCO, the Atlantic Lottery Corporation and Alberta&#39;s AGLC.

Under the terms of the agreement, Pariplay will add and market Playgon&#39;s proprietary mobile-first live dealer and E-table offerings under the VegasLounge&trade; brand, to its content library for availability and distribution to all of Pariplay&#39;s global client base. The agreement is for two years with license fees based on commercial revenue sharing rates. Integration work is near completion and client testing and on-boarding will start imminently.

Callum Harris, Director of Partnerships at Pariplay, said:&nbsp;&quot;Playgon has successfully developed a unique live dealer product with well-designed game play features that use cutting-edge technology to deliver a unique playing experience that particularly appeals to a different demographic. It is great to welcome Playgon to the Fusion&trade; platform, where its blend of live dealer casino and eTable games will entertain players all over the world.&quot;

Darcy Krogh, President and CEO at Playgon, said:&nbsp;&quot;Pariplay&#39;s Fusion&trade; platform enables us to reach new customers and new jurisdictions globally, so it&#39;s a meaningful deal for us with a provider that has in place a series of partnerships with major operators in high-profile markets. We believe our games are modern, innovative, and designed with a mobile mindset in order to stand apart from the competition. This agreement with Pariplay will certainly help us accelerate our growth.&quot;

NGMS

Playgon Games Enters Into A Licensing And Distribution Agreement With Pariplay

The following post was written and/or published as a collaboration between Benzinga&rsquo;s in-house sponsored content team and a financial partner of Benzinga.

As 2021 continues, some of the biggest trends of last year are also continuing, including the huge growth of esports and video games.&nbsp;

According to research firm Newzoo, the global esports market will generate over $1 billion in revenue this year, and nearly 475 million people will be involved in esports in some way.&nbsp;

&ldquo;We believe that video gaming and esports represent a structural long-term growth trend, which equates to growth that&rsquo;s being supported by other trends and has the potential to keep growing for an extended period of time,&rdquo; said John Patrick Lee, ETF Product Manager at VanEck.&nbsp;

One of the biggest trends, according to Lee, is the growth of mobile gaming, which is the fastest-growing segment of the esports and gaming industry.&nbsp;

Investors are likely familiar with some of the largest esports companies. But what they may not realize is there are many other companies well-positioned to capitalize on the growth of the industry.&nbsp;

&ldquo;In some ways, the companies trading on OTC Markets are capturing some of the most exciting themes that are driving the industry. Activision Blizzard (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATVI#NASDAQ">ATVI</a>) is a successful company that&rsquo;s firing on all cylinders, but it&rsquo;s important to keep in mind that it&rsquo;s also a big multi-billion dollar company. On the other hand, earlier stage companies like those trading on OTC may have the potential for higher growth, as these are generally younger companies in a different part of their life cycle when compared to a large or mega-cap company,&rdquo; Lee told Benzinga.&nbsp;

Investors will get to hear directly from these companies on Thursday at the Virtual Investor Conference&rsquo;s Esports &amp; Gaming Conference. In addition to a keynote presentation hosted by VanEck, executives from 11 emerging esports and gaming companies will discuss their involvement in the space and the trends they see unfolding, as well.&nbsp;

Below is the schedule for the conference. Each presentation will be followed by a Q&amp;A session with investors afterward and will also be available on demand.

To register for the free conference, <a href="https://www.virtualinvestorconferences.com/events/event-details/e-sportsgaming-virtual-investor-conference?utm_source=Article&amp;utm_medium=Benzinga&amp;utm_campaign=04%2029%202021%20Esports">click here</a>.&nbsp;

April 29th Agenda:&nbsp;

9:15 AM ET&nbsp;&nbsp;&nbsp; 
Keynote Presentation - Video Gaming &amp; Esports: Taking Media and Entertainment to the Next Level 
Edward Lopez, Managing Director, Head of ETF Product 
John Patrick Lee, ETF Product Manager

10:00 AM ET 
Playgon Games Inc. (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/PLGNF#OTCQB">PLGNF</a>, TSXV:<a class="ticker" href="https://www.benzinga.com/stock/DEAL#TSXV">DEAL</a>) 
Industry: Developer/Licenser 
Speakers: Darcy Krogh, CEO; Steve Baker, COO

10:30 AM ET&nbsp; 
PopReach Corporation (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/POPRF#OTCQX">POPRF</a>, TSXV:<a class="ticker" href="https://www.benzinga.com/stock/POPR#TSXV">POPR</a>) 
Industry: Mobile Gaming 
Speaker: Jon Walsh, CEO

11:00 AM ET 
G5 Entertainment AB (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/GENTF#OTCQX">GENTF</a>, Nasdaq Stockholm: G5EN.ST)) 
Industry: Developer 
Speaker: Vlad Suglobov, Co-Founder, CEO, Member of the Board

11:30 AM ET 
Astralis Group A/S (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ASGRF#OTC">ASGRF</a>, Nasdaq First North Copenhagen: ASTRGRP.CO)) 
Industry: Esports and Gaming 
Speaker: Nikolaj Nyholm, Founder and Chairman

12:00 PM ET 
Gaming Realms PLC (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PSDMF#OTC">PSDMF</a>, LON: GMR)) 
Industry: Gaming 
Speakers: Michael Buckley, Executive Chairman; Mark Segal, CFO

12:30 PM ET 
OverActive Media (Private Company) 
Industry: Esports 
Speakers: Chris Overholt, President and CEO

1:00 PM ET 
GameSquare Esports Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GMSQF#OTC">GMSQF</a>, CSE:<a class="ticker" href="https://www.benzinga.com/stock/GSQ#CSE">GSQ</a>) 
Industry: Esports 
Speakers: Justin Kenna, CEO; Kevin Wright, President

1:30 PM ET 
LeoVegas AB (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/LEOVF#OTCQX">LEOVF</a>, Nasdaq Stockholm: LEO)) 
Industry: Mobile Casino 
Speakers: Gustaf Hagman, CEO; Stefan Nelson, CFO

2:00 PM ET 
FansUnite Entertainment Inc. (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/FUNFF#OTCQB">FUNFF</a>, CSE:<a class="ticker" href="https://www.benzinga.com/stock/FANS#CSE">FANS</a>) 
Industry: Gaming 
Speaker: Scott Burton, CEO

2:30 PM ET 
TGS Esports Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGSEF#OTC">TGSEF</a>, TSXV:<a class="ticker" href="https://www.benzinga.com/stock/TGS#TSXV">TGS</a>) 
Industry: Esports 
Speaker: Spiro Khouri, CEO

3:00 PM ET 
Real Luck Group Ltd. (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/LUKEF#OTCQB">LUKEF</a>, TSXV:<a class="ticker" href="https://www.benzinga.com/stock/LUCK#TSXV">LUCK</a>) 
Industry: Esports 
Speaker: Quentin Martin, CEO

To register for the free conference, <a href="https://www.virtualinvestorconferences.com/events/event-details/e-sportsgaming-virtual-investor-conference?utm_source=Article&amp;utm_medium=Benzinga&amp;utm_campaign=04%2029%202021%20Esports">click here</a>.&nbsp;&nbsp;

&nbsp;

 
Additional Disclosure:&nbsp;

Please note that VanEck may offer investment products that invest in the asset class(es) or industries included in this webinar.&nbsp;

The information we provide does not constitute any form of a financial opinion or investment advice on the part of VanEck or any of its affiliates and it should not be relied on as such. It does not constitute a prospectus, offering memorandum, or private placement memorandum in Canada, and may not be used in making any investment decision. It should not be considered a solicitation to buy or an offer to sell a security in any jurisdiction. This information is provided for informational and educational use only.

Certain statements contained herein may constitute projections, forecasts, and other forward-looking statements, which do not reflect actual results, are valid as of the date of this communication and subject to change without notice. Information provided by third-party sources are believed to be reliable and have not been independently verified for accuracy or completeness and cannot be guaranteed. VanEck does not guarantee the accuracy of 3rd party data. The information herein represents the opinion of the author(s), but not necessarily those of VanEck.

All investing is subject to risk, including the possible loss of the money you invest. As with any investment strategy, there is no guarantee that investment objectives will be met and investors may lose money. Diversification does not ensure a profit or protect against a loss in a declining market. Past performance is no guarantee of future results. 
The preceding post was written and/or published as a collaboration between Benzinga&rsquo;s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.

Comments

Playgon Games

News

Latest news for Playgon Games (OTC:PLGNF) Stock

Wednesday, September 07, 2022

Wednesday, April 28, 2021

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga